| Oct 19 |
Positive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past year
|
| Oct 16 |
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Oct 9 |
OptiNose Inc (OPTN) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...
|
| Oct 7 |
Optinose names Terry Kohler as CFO
|
| Oct 7 |
Optinose Appoints Terry Kohler as Chief Financial Officer
|
| Sep 13 |
OptiNose (NASDAQ:OPTN) shareholders have endured a 88% loss from investing in the stock five years ago
|
| Sep 5 |
New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery
|
| Aug 26 |
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 11 |
OptiNose, Inc. (OPTN) Q2 2024 Earnings Call Transcript
|
| Aug 10 |
OptiNose Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
